Jun 23,2023

The $30.4 Billion Diabetes Market in Germany, Forecast to 2028 Featuring Abbott Laboratories, Roche Diagnostic, Medtronic and Eli Lilly Among Others

The diabetes market in Germany is projected to reach USD 30.4 billion by 2028, with a CAGR of 5.92%, according to the publisher. The increasing prevalence of diabetes, particularly type 2 diabetes among older adults, poses challenges for the healthcare system. Technological innovations in insulin delivery systems and digital health solutions offer convenience in managing blood glucose levels. The German government's initiative to cover medically necessary treatments, including insulin drugs, helps reduce out-of-pocket expenses for diabetes patients.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 23,2023

American Diabetes Association to Highlight Innovations in Diabetic Eye Condition

Another study presented at the ADA conference in San Diego, CA highlighted the use of AI to diagnose diabetic retinopathy. The study, Identifying the Risk of Diabetic Retinopathy (DR) Progression Using Machine Learning on Ultrawide Field Retinal Images, examined the use of AI algorithms to improve the process of estimating the risk of DR progression. In this study, the authors developed and validated machine learning (ML) models for DR progression from ultrawide field (UWF) retinal images, which were labeled for baseline DR severity and progression. Findings show the AI prediction for 91% of the images were either correct labels or were the labels with greater progression than the original labels.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jun 23,2023

A Dual Function Glucose Sensing Insulin Delivery Technology Is Presented at the 83rd Scientific Sessions of the American Diabetes Association

One of the studies presented at the ADA conference in San Diego, CA was about the SynerG, a dual-function glucose sensing-insulin delivery device developed by Pacific Diabetes Technologies that simplifies diabetes management. The SynerG glucose sensor has a warm-up time of less than 30 min and also synchronizes replacement schedules for insulin delivery and glucose measurement functions. Feasibility of a Prototype Dual Function Glucose Sensing Insulin Delivery Cannula in People with Type 1 Diabetes, showed the feasibility of the first single through-the-skin device combining glucose sensing and insulin delivery functions (SynerG). The study enrolled 24 adults with type 1 diabetes on insulin pump therapy (IPT). The device was inserted subcutaneously in the anterior abdomen and attached to the pump, following a 48-hour run-in using a commercially available infusion set with a study pump. Findings for 24 participants indicate that insulin did not interfere with the function of the glucose sensor and demonstrated accuracy in the measurement of glucose. In addition, insulin was delivered reliably to participants.

CLINICAL STUDY

#cgm

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 23,2023

Medtronic presents new data on MiniMed™ 780G system on fixed meal dosing and real-world Time in Range across wide variety of users

Medtronic presented new clinical and real-world data on the MiniMed™ 780G system at the 83rd American Diabetes Association Scientific Sessions. The data showed that the system's Meal Detection™ technology supported Time in Range outcomes exceeding consensus guidelines of 70% and helped reduce hyperglycemia. A study also demonstrated that simplified meal announcements using the system helped users maintain glycemic targets and reduce hyperglycemia. Real-world evidence showed strong performance in children, and data on the Medtronic Extended Infusion™ Set demonstrated reduced user burden through less frequent set changes.

CLINICAL STUDY

#insulin pump

#cgm

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 23,2023

Kakao Healthcare launching Dexcom-powered diabetes management service

Dexcom has partnered with Kakao Healthcare, the digital healthcare division of South Korean company Kakao Corporation, to launch a global digital diabetes management service. The collaboration combines Kakao Healthcare's AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices. The service will be launched in South Korea initially and later expanded to the United States, the Middle East, and Japan. Kakao Healthcare aims to improve public health and contribute to the global expansion of digital healthcare.

COLLABORATION PARTNERSHIP

#connected device

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 23,2023

Dexcom Updates Long-Range Financial Targets

Dexcom has updated its long-range financial targets, reflecting its strong performance in the first two years of the target period. The updated targets for the year-end 2025 include revenue of approximately $4.6 - $5.1 billion, non-GAAP gross profit margin of 65%, non-GAAP operating profit margin of 21%, and adjusted EBITDA margin of 31%. Dexcom credits its innovative sensing technology and growing global customer base for the upward adjustment of its financial targets.

View Analyst & Ambassador Comments
Go to original news
Jun 24,2023

THE AMERICAN DIABETES ASSOCIATION AND ABBOTT COLLABORATE ON FIRST-OF-ITS-KIND THERAPEUTIC NUTRITION PROGRAM FOR PEOPLE WITH DIABETES

The American Diabetes Association (ADA) and Abbott are collaborating on a unique therapeutic nutrition program for individuals with diabetes. Abbott is providing a $2.65 million grant over three years to the ADA to support the initiative. The collaboration aims to understand how diabetes technology, such as continuous glucose monitoring (CGM) systems, can assist people in making informed decisions about their diet and activity. Through pilot programs, engagement with healthcare professionals, and roundtable discussions, the partnership seeks to evaluate the effectiveness of CGM systems in personalized therapeutic nutrition.

COLLABORATION PARTNERSHIP

#r&d

#cgm

View Analyst & Ambassador Comments
Go to original news

Digital Diabetes Partnership Ecosystems Explained: Introducing the Ecosystem Types and Builders

Summary

This expert-led presentation on the partnership ecosystems in digital diabetes market sheds light on the ecosystem types that have been built by the market competitors since 2014, and dives into the profiles of the ecosystem builders in digital diabetes market segment.

Author: Melis Ince, Senior Market Analyst and Consultant at Research2Guidance

Mar 14,2023

SelectHealth brings Vida Health virtual health solutions to members managing chronic conditions

SelectHealth®, a nonprofit health plan serving more than one million members in Utah, Idaho, and Nevada, is pleased to announce a new relationship with virtual cardiometabolic care leader Vida Health effective March 2023. The relationship provides SelectHealth Medicare Advantage and Individual plan members with access to Vida’s virtual cardiometabolic solutions for chronic physical and mental health conditions. Eligible SelectHealth members can now tap Vida’s extensive resources for chronic conditions and associated mental health ailments, such as diabetes, hypertension, congestive heart failure, chronic obstructive pulmonary disease (COPD), depression and anxiety. Resources include licensed therapists, dietitians, diabetes educators and certified health coaches.

COLLABORATION PARTNERSHIP

#insurance

#coaching

View Analyst & Ambassador Comments
Go to original news
Feb 13,2023

Vida Health expands its cardiometabolic capabilities to include GLP-1s for diabetes management and weight loss

Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES